BioSpace News Archive

Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for FMX103

A new RealSelf survey conducted online by The Harris Poll¹ reveals 59 percent of women in the U.S. do not know there is a difference between a cosmetic surgeon and a plastic surgeon.

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will release financial results for the three and six months ended June 30, 2019 after the market closes on Monday, August 12, 2019

Tetra Discovery Partners, a clinical-stage biotechnology company, today announced the company’s name change to Tetra Therapeutics

Product expansion comes as UnitedHealthcare issues positive coverage decision on PGx testing, including Genomind’s service, for certain patients with major depressive disorder or anxiety

Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company.

Nissui Pharmaceutical Co., Ltd., based in Tokyo, is pleased to announce that @BactLAB, an application that uses Amazon Web Service Cloud and artificial intelligence technologies to enable quick and easy counting of bacterial colonies, is now available to overseas users of CompactDry.

Sage Therapeutics, Inc. announced that on August 1, 2019, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 11,550 shares of its common stock, and 1,925 performance restricted stock units to seven new employees under Sage’s 2016 Inducement Equity Plan.

Renowned Surgeon and Researcher Will Help Inform Independent Nonprofit’s Research and Policy-Related Initiatives

Compugen Ltd. reported financial results for the second quarter ended June 30, 2019.